Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alexza Pharmaceuticals and Autoliv ASP, the North American subsidiary of Sweden-based Autoliv, have announced the completion of a commercial manufacturing and supply agreement for chemical heat packages, a key component of Alexza's novel single-dose Staccato system.
Subscribe to our email newsletter
The portable and easy to use single-dose Staccato devices each contain a metal heat package that is chemically heated through a battery- initiated reaction of energetic materials. Alexza single-dose Staccato devices are used in a majority of its current product candidates.
Mike Ward, president of Autoliv’s North American division, said: “As the largest manufacturer of airbags and seatbelts worldwide, our business focus is saving lives. Partnering with Alexza to manufacture a component of an effective delivery technology for drug therapies based on the use of energetic materials is a natural extension of what we are already doing every day.”
Thomas King, president and CEO of Alexza, said: “With the completion of this supply agreement with Autoliv, we are executing on our global commercial manufacturing supply strategy. Our strategy includes solidifying supply relationships with leading companies for each of the key device components of our Staccato-based products. Autoliv’s quality excellence, cost efficiency and technological leadership in manufacturing with energetic materials makes Autoliv an ideal strategic partner for us, as we advance our product candidates into late-stage development and toward commercialization.”